Inflamed actinic keratoses as a biomarker in repositioning of chemotherapeutics: a systematic review and meta-analysis
Background Inflammation of actinic keratoses (AK) was originally described with systemic 5-fluorouracil, and led to the development of topical fluorouracil. Similar observations using different chemotherapeutics may point to other drugs with a potential for repositioning. Objective This systematic r...
Main Authors: | Špela Šuler Baglama, Irena Peteln, Gregor B. E. Jemec |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2022-11-01
|
Series: | Journal of Dermatological Treatment |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/09546634.2022.2131298 |
Similar Items
-
Inflammation of Actinic Keratoses Induced by Combination of Carboplatin and Paclitaxel: Two Case Reports
by: Špela Šuler Baglama, et al.
Published: (2022-12-01) -
AKASI and Near-Infrared Spectroscopy in the combined effectiveness evaluation of an actinic keratoses preventive product in immunocompetent and immunocompromised patients
by: Federica Veronese, et al.
Published: (2022-09-01) -
Malignant transformation of actinic keratoses to squamous cell carcinoma in an albino
by: Ramalingam Vijaya, et al.
Published: (2009-01-01) -
Combination-Based Strategies for the Treatment of Actinic Keratoses with Photodynamic Therapy: An Evidence-Based Review
by: Stefano Piaserico, et al.
Published: (2022-08-01) -
Patient assessment of 5-fluorouracil and imiquimod for the treatment of actinic keratoses: a retrospective study of real-world effectiveness
by: Veronica K. Emmerich, et al.
Published: (2022-05-01)